SHL Telemedicine Ltd. (SHLT)
USD 2.05
(0.99%)
USD 2.05
(0.99%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 36.58 Million USD | -28.95% |
| 2022 | 51.49 Million USD | -25.19% |
| 2021 | 68.82 Million USD | 155.53% |
| 2020 | 26.93 Million USD | 7.5% |
| 2019 | 25.05 Million USD | 40.43% |
| 2018 | 17.84 Million USD | -50.84% |
| 2017 | 36.29 Million USD | -6.49% |
| 2016 | 38.81 Million USD | 21.84% |
| 2015 | 31.85 Million USD | 3.66% |
| 2014 | 30.73 Million USD | -22.41% |
| 2013 | 39.6 Million USD | 2.21% |
| 2012 | 38.74 Million USD | -6.93% |
| 2011 | 41.63 Million USD | 104.4% |
| 2010 | 20.36 Million USD | -4.25% |
| 2009 | 21.27 Million USD | -6.5% |
| 2008 | 22.75 Million USD | -72.81% |
| 2007 | 83.66 Million USD | -15.07% |
| 2006 | 98.51 Million USD | 1.99% |
| 2005 | 96.59 Million USD | -15.44% |
| 2004 | 114.22 Million USD | 4.92% |
| 2003 | 108.87 Million USD | -6.01% |
| 2002 | 115.83 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 32.57 Million USD | 0.0% |
| 2024 Q1 | 32.57 Million USD | -10.97% |
| 2023 Q1 | 40.19 Million USD | -21.94% |
| 2023 Q3 | 36.58 Million USD | -8.97% |
| 2023 Q4 | 36.58 Million USD | 0.0% |
| 2023 FY | 36.58 Million USD | -28.95% |
| 2023 Q2 | 40.19 Million USD | -0.0% |
| 2022 Q1 | 58.64 Million USD | -14.79% |
| 2022 Q3 | 51.49 Million USD | -12.2% |
| 2022 Q4 | 51.49 Million USD | 0.0% |
| 2022 FY | 51.49 Million USD | -25.19% |
| 2022 Q2 | 58.64 Million USD | 0.0% |
| 2021 Q4 | 68.82 Million USD | 0.0% |
| 2021 Q2 | 37.78 Million USD | 0.0% |
| 2021 Q1 | 37.78 Million USD | 40.27% |
| 2021 FY | 68.82 Million USD | 155.53% |
| 2021 Q3 | 68.82 Million USD | 82.17% |
| 2020 Q1 | 25.69 Million USD | 2.53% |
| 2020 Q4 | 26.93 Million USD | 0.0% |
| 2020 Q2 | 25.69 Million USD | 0.0% |
| 2020 FY | 26.93 Million USD | 7.5% |
| 2020 Q3 | 26.93 Million USD | 4.85% |
| 2019 Q3 | 25.05 Million USD | 22.09% |
| 2019 Q1 | 20.52 Million USD | 15.02% |
| 2019 Q2 | 20.52 Million USD | 0.0% |
| 2019 FY | 25.05 Million USD | 40.43% |
| 2019 Q4 | 25.05 Million USD | 0.0% |
| 2018 Q1 | 30.96 Million USD | -14.68% |
| 2018 FY | 17.84 Million USD | -50.84% |
| 2018 Q4 | 17.84 Million USD | 9.42% |
| 2018 Q3 | 16.3 Million USD | -47.34% |
| 2018 Q2 | 30.96 Million USD | 0.0% |
| 2017 FY | 36.29 Million USD | -6.49% |
| 2017 Q2 | 39.54 Million USD | 0.0% |
| 2017 Q1 | 39.54 Million USD | 1.88% |
| 2017 Q4 | 36.29 Million USD | 0.0% |
| 2017 Q3 | 36.29 Million USD | -8.22% |
| 2016 Q1 | 32.6 Million USD | -0.13% |
| 2016 FY | 38.81 Million USD | 21.84% |
| 2016 Q4 | 38.81 Million USD | 0.0% |
| 2016 Q3 | 38.81 Million USD | 19.05% |
| 2016 Q2 | 32.6 Million USD | 0.0% |
| 2015 Q2 | 34.01 Million USD | 5.85% |
| 2015 Q1 | 32.13 Million USD | 4.58% |
| 2015 Q4 | 32.64 Million USD | 0.0% |
| 2015 FY | 31.85 Million USD | 3.66% |
| 2015 Q3 | 32.64 Million USD | -4.03% |
| 2014 Q2 | 37.48 Million USD | -4.68% |
| 2014 Q1 | 39.32 Million USD | -0.71% |
| 2014 FY | 30.73 Million USD | -22.41% |
| 2014 Q4 | 30.73 Million USD | -5.42% |
| 2014 Q3 | 32.49 Million USD | -13.32% |
| 2013 Q4 | 39.6 Million USD | 8.64% |
| 2013 FY | 39.6 Million USD | 2.21% |
| 2013 Q1 | 37.07 Million USD | -4.31% |
| 2013 Q2 | 35.23 Million USD | -4.98% |
| 2013 Q3 | 36.45 Million USD | 3.47% |
| 2012 Q2 | 35.65 Million USD | -16.73% |
| 2012 Q4 | 38.74 Million USD | 9.9% |
| 2012 FY | 38.74 Million USD | -6.93% |
| 2012 Q1 | 42.81 Million USD | 2.85% |
| 2012 Q3 | 35.25 Million USD | -1.11% |
| 2011 Q3 | 44.23 Million USD | 105.32% |
| 2011 Q2 | 21.54 Million USD | 1.39% |
| 2011 Q1 | 21.24 Million USD | 4.32% |
| 2011 FY | 41.63 Million USD | 104.4% |
| 2011 Q4 | 41.63 Million USD | -5.88% |
| 2010 Q4 | 20.36 Million USD | -10.58% |
| 2010 Q1 | 23.03 Million USD | 8.28% |
| 2010 Q2 | 20.31 Million USD | -11.82% |
| 2010 Q3 | 22.77 Million USD | 12.14% |
| 2010 FY | 20.36 Million USD | -4.25% |
| 2009 FY | 21.27 Million USD | -6.5% |
| 2009 Q2 | 21.22 Million USD | 0.0% |
| 2009 Q4 | 21.27 Million USD | 0.0% |
| 2008 FY | 22.75 Million USD | -72.81% |
| 2007 FY | 83.66 Million USD | -15.07% |
| 2006 FY | 98.51 Million USD | 1.99% |
| 2005 FY | 96.59 Million USD | -15.44% |
| 2004 FY | 114.22 Million USD | 4.92% |
| 2003 FY | 108.87 Million USD | -6.01% |
| 2002 FY | 115.83 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accolade, Inc. | 342.68 Million USD | 89.323% |
| Aclarion, Inc. | 3.18 Million USD | -1047.769% |
| Aclarion, Inc. | 3.18 Million USD | -1047.769% |
| Augmedix, Inc. | 43.39 Million USD | 15.678% |
| HeartBeam, Inc. | 1.19 Million USD | -2964.34% |
| HeartBeam, Inc. | 1.19 Million USD | -2964.34% |
| Bullfrog AI Holdings, Inc. Common Stock | 184.35 Thousand USD | -19747.148% |
| Bullfrog AI Holdings, Inc. Warrants | 184.35 Thousand USD | -19747.148% |
| BrightSpring Health Services, Inc. Common Stock | 5.17 Billion USD | 99.293% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 5.17 Billion USD | 99.293% |
| CareCloud, Inc. | 37.79 Million USD | 3.198% |
| CareCloud, Inc. | 37.79 Million USD | 3.198% |
| CareCloud, Inc. | 37.79 Million USD | 3.198% |
| Certara, Inc. | 516.29 Million USD | 92.913% |
| CareMax, Inc. | 561.85 Million USD | 93.488% |
| CareMax, Inc. | 561.85 Million USD | 93.488% |
| Definitive Healthcare Corp. | 626.72 Million USD | 94.162% |
| EUDA Health Holdings Limited | 8.79 Million USD | -316.132% |
| EUDA Health Holdings Limited | 8.79 Million USD | -316.132% |
| Forian Inc. | 33.19 Million USD | -10.218% |
| GoodRx Holdings, Inc. | 826.84 Million USD | 95.575% |
| GE HealthCare Technologies Inc. | 25.14 Billion USD | 99.854% |
| Health Catalyst, Inc. | 334.89 Million USD | 89.075% |
| Healthcare Triangle, Inc. | 9.51 Million USD | -284.694% |
| HealthEquity, Inc. | 1.2 Billion USD | 96.955% |
| HealthStream, Inc. | 159.19 Million USD | 77.016% |
| iCoreConnect Inc. | 11.24 Million USD | -225.45% |
| Inovalon Holdings, Inc. | 1.26 Billion USD | 97.102% |
| MSP Recovery, Inc. | 1.74 Billion USD | 97.898% |
| Mangoceuticals, Inc. | 276.03 Thousand USD | -13154.727% |
| National Research Corporation | 73.48 Million USD | 50.208% |
| Nutex Health, Inc. | 319.13 Million USD | 88.535% |
| Omnicell, Inc. | 1.03 Billion USD | 96.475% |
| OneMedNet Corporation | 13.32 Million USD | -174.631% |
| OptimizeRx Corporation | 56.82 Million USD | 35.608% |
| Ontrak, Inc. | 5.57 Million USD | -556.291% |
| Ontrak, Inc. | 5.57 Million USD | -556.291% |
| Progyny, Inc. | 203.19 Million USD | 81.993% |
| Premier, Inc. | 1.46 Billion USD | 97.505% |
| Privia Health Group, Inc. | 392.51 Million USD | 90.678% |
| R1 RCM Inc. | 2.2 Billion USD | 98.344% |
| Renalytix Plc | 15.82 Million USD | -131.191% |
| Schrödinger, Inc. | 254.39 Million USD | 85.618% |
| Sharecare, Inc. | 125.56 Million USD | 70.861% |
| Sharecare, Inc. | 125.56 Million USD | 70.861% |
| Simulations Plus, Inc. | 14.2 Million USD | -157.518% |
| SOPHiA GENETICS SA | 54.71 Million USD | 33.128% |
| Spok Holdings, Inc. | 63.91 Million USD | 42.753% |
| Streamline Health Solutions, Inc. | 22.92 Million USD | -59.593% |
| TruBridge, Inc. | 247.8 Million USD | 85.235% |
| 10x Genomics, Inc. | 224.1 Million USD | 83.673% |
| Minerva Surgical, Inc. | 51.71 Million USD | 29.256% |
| GeneDx Holdings Corp. | 245.65 Million USD | 85.106% |
| GeneDx Holdings Corp. | 245.65 Million USD | 85.106% |
| SCWorx Corp. | 2.42 Million USD | -1408.938% |
| Zhongchao Inc. | 3.37 Million USD | -982.981% |